Medicare Enrolled

Dr. Nadege Gunn, M.D.

Gastroenterology · Waco, TX
Speaking/Promotional
6600 FISH POND RD STE 103, Waco, TX 76710
2542944780
In practice since 2006 (19 years)
NPI: 1902822281 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gunn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gunn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gunn

Dr. Nadege Gunn is a gastroenterology in Waco, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Gunn received a total of $501,781 from 45 pharmaceutical and/or device companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gunn is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $501,781 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$501,781
Total received (2018-2024)
Avg $71,683/year across 7 years
Top 1% in TX for gastroenterology
45
Companies
860
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$380,366 (75.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$109,617 (21.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,799 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$208,252
2023
$63,386
2022
$51,452
2021
$34,340
2020
$23,269
2019
$64,813
2018
$56,270

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$213,987
Novo Nordisk Inc
$68,958
Madrigal Pharmaceuticals
$53,155
Intercept Pharmaceuticals, Inc.
$41,293
Ipsen Biopharmaceuticals, Inc
$36,063
AbbVie, Inc.
$30,809
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,697
Eli Lilly and Company
$9,938
Mirum Pharmaceuticals, Inc.
$6,753
PFIZER INC.
$5,196
AbbVie Inc.
$3,313
Siemens Medical Solutions USA, Inc.
$2,400
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,063
Kowa Research Institute, Inc.
$1,523
Celgene Corporation
$1,394
Boehringer Ingelheim International GmbH
$1,321
Perspectum Diagnostics Ltd
$821
Shionogi Inc
$797
Echosens North America, Inc.
$595
Takeda Pharmaceuticals U.S.A., Inc.
$371
INTERCEPT PHARMACEUTICALS, INC.
$352
Dova Pharmaceuticals
$287
Lilly USA, LLC
$208
UCB, Inc.
$190
ABBVIE INC.
$149
E.R. Squibb & Sons, L.L.C.
$128
Exact Sciences Corporation
$126
Ortho Dermatologics, a division of Bausch Health US, LLC
$118
AstraZeneca Pharmaceuticals LP
$97
Amgen Inc.
$97
Janssen Scientific Affairs, LLC
$97
Ipsen Pharma SAS
$75
Romark Laboratories, LC
$52
Novo Nordisk AS
$50
Intuitive Surgical, Inc.
$50
FUJIFILM Healthcare Americas Corporation
$45
Ultragenyx Pharmaceutical Inc.
$41
ALBIREO PHARMA, INC.
$35
Exelixis Inc.
$32
Daiichi Sankyo Inc.
$22
Alnylam Pharmaceuticals Inc.
$20
EISAI INC.
$18
QOL Medical, LLC
$15
Ironwood Pharmaceuticals, Inc
$14
Janssen Biotech, Inc.
$14
Top 3 companies account for 67.0% of total payments
Associated products mentioned in payments ›
ACUSON Sequoia Diagnostic Ultrasound System · ALINIA · APRISO · Bylvay · CRYSVITA · Cabometyx · Cimzia · Creon · Da Vinci Surgical System · Doptelet · ELIQUIS · ENTYVIO · Entyvio · Epclusa · FibroScan · Fibroscan · GATTEX · GIVLAARI · HUMIRA · Hepsera · Humira · INJECTAFER · IQIRVO · LINZESS · Lenvima · Linzess · Livdelzi · LiverMultiScan · Livmarli · MAVYRET · MOUNJARO · Mavyret · Mulpleta · OCALIVA · OPDIVO · Ozanimod · Ozempic · RESMETIROM · REZDIFFRA · RIFAXIMIN · RINVOQ · RYBELSUS · Rybelsus · STELARA · Sucraid · TEZSPIRE · TRULANCE · TRULICITY · UTASWAKO AFP-L3 · Vemlidy · Wegovy · XELJANZ · XIFAXAN · ZEPBOUND · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in TX.

Looking for a gastroenterology in Waco?
Compare gastroenterologys in the Waco area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
14
Per 100K population
5.3
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
4.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gunn is a gastroenterology, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Gunn receive payments from pharmaceutical companies?
Yes. Dr. Gunn received a total of $501,781 from 45 companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Gunn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →